These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 37696679)

  • 21. Effect of clinician-patient communication on compliance with flupentixol-melitracen in functional dyspepsia patients.
    Yan XJ; Li WT; Chen X; Wang EM; Liu Q; Qiu HY; Cao ZJ; Chen SL
    World J Gastroenterol; 2015 Apr; 21(15):4652-9. PubMed ID: 25914475
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Proton pump inhibitors for functional dyspepsia.
    Pinto-Sanchez MI; Yuan Y; Bercik P; Moayyedi P
    Cochrane Database Syst Rev; 2017 Mar; 3(3):CD011194. PubMed ID: 28271513
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparing omeprazole with fluoxetine for treatment of patients with heartburn and normal endoscopy who failed once daily proton pump inhibitors: double-blind placebo-controlled trial.
    Ostovaneh MR; Saeidi B; Hajifathalian K; Farrokhi-Khajeh-Pasha Y; Fotouhi A; Mirbagheri SS; Emami H; Barzin G; Mirbagheri SA
    Neurogastroenterol Motil; 2014 May; 26(5):670-8. PubMed ID: 24533896
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Double blind, randomised, placebo controlled study of four weeks of lansoprazole for the treatment of functional dyspepsia in Chinese patients.
    Wong WM; Wong BC; Hung WK; Yee YK; Yip AW; Szeto ML; Fung FM; Tong TS; Lai KC; Hu WH; Yuen MF; Lam SK
    Gut; 2002 Oct; 51(4):502-6. PubMed ID: 12235071
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Poliprotect vs Omeprazole in the Relief of Heartburn, Epigastric Pain, and Burning in Patients Without Erosive Esophagitis and Gastroduodenal Lesions: A Randomized, Controlled Trial.
    Corazziari ES; Gasbarrini A; D'Alba L; D'Ovidio V; Riggio O; Passaretti S; Annibale B; Cicala M; Repici A; Bassotti G; Ciacci C; Di Sabatino A; Neri M; Bragazzi MC; Ribichini E; Radocchia G; Iovino P; Marazzato M; Schippa S; Badiali D
    Am J Gastroenterol; 2023 Nov; 118(11):2014-2024. PubMed ID: 37307528
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect and cost-effectiveness of step-up versus step-down treatment with antacids, H2-receptor antagonists, and proton pump inhibitors in patients with new onset dyspepsia (DIAMOND study): a primary-care-based randomised controlled trial.
    van Marrewijk CJ; Mujakovic S; Fransen GA; Numans ME; de Wit NJ; Muris JW; van Oijen MG; Jansen JB; Grobbee DE; Knottnerus JA; Laheij RJ
    Lancet; 2009 Jan; 373(9659):215-25. PubMed ID: 19150702
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Randomised clinical trial: rabeprazole improves symptoms in patients with functional dyspepsia in Japan.
    Iwakiri R; Tominaga K; Furuta K; Inamori M; Furuta T; Masuyama H; Kanke K; Nagahara A; Haruma K; Kinoshita Y; Higuchi K; Takahashi S; Kusano M; Iwakiri K; Kato M; Hongo M; Hiraishi H; Watanabe S; Miwa H; Naito Y; Fujimoto K; Arakawa T
    Aliment Pharmacol Ther; 2013 Oct; 38(7):729-40. PubMed ID: 23957383
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Classification of dyspepsia. Identification of independent symptom components in 7270 consecutive, unselected dyspepsia patients from general practice.
    Meineche-Schmidt V; Christensen E
    Scand J Gastroenterol; 1998 Dec; 33(12):1262-72. PubMed ID: 9930389
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Helicobacter pylori eradication and standardized 3-month omeprazole therapy in functional dyspepsia.
    Koskenpato J; Farkkilä M; Sipponen P
    Am J Gastroenterol; 2001 Oct; 96(10):2866-72. PubMed ID: 11693319
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of curcumin-pipeine supplementation on clinical status, mortality rate, oxidative stress, and inflammatory markers in critically ill ICU patients with COVID-19: a structured summary of a study protocol for a randomized controlled trial.
    Askari G; Alikiaii B; Soleimani D; Sahebkar A; Mirjalili M; Feizi A; Iraj B; Bagherniya M
    Trials; 2021 Jul; 22(1):434. PubMed ID: 34229742
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Eradication of Helicobacter pylori in functional dyspepsia: randomised double blind placebo controlled trial with 12 months' follow up. The Optimal Regimen Cures Helicobacter Induced Dyspepsia (ORCHID) Study Group.
    Talley NJ; Janssens J; Lauritsen K; Rácz I; Bolling-Sternevald E
    BMJ; 1999 Mar; 318(7187):833-7. PubMed ID: 10092259
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of profound acid suppression in functional dyspepsia: a double-blind, randomized, placebo-controlled trial.
    Bolling-Sternevald E; Lauritsen K; Aalykke C; Havelund T; Knudsen T; Unge P; Ekström P; Jaup B; Norrby A; Stubberöd A; Melén K; Carlsson R; Jerndal P; Junghard O; Glise H
    Scand J Gastroenterol; 2002 Dec; 37(12):1395-402. PubMed ID: 12523588
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Low-dose imipramine for refractory functional dyspepsia: a randomised, double-blind, placebo-controlled trial.
    Cheong PK; Ford AC; Cheung CKY; Ching JYL; Chan Y; Sung JJY; Chan FKL; Wu JCY
    Lancet Gastroenterol Hepatol; 2018 Dec; 3(12):837-844. PubMed ID: 30361080
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Gaviscon® vs. omeprazole in symptomatic treatment of moderate gastroesophageal reflux. a direct comparative randomised trial.
    Pouchain D; Bigard MA; Liard F; Childs M; Decaudin A; McVey D
    BMC Gastroenterol; 2012 Feb; 12():18. PubMed ID: 22361121
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of wu chu yu tang on gastroesophageal reflux disease: Randomized, double-blind, placebo-controlled trial.
    Shih YS; Tsai CH; Li TC; Yu CJ; Chou JW; Feng CL; Wang KT; Lai HC; Hsieh CL
    Phytomedicine; 2019 Mar; 56():118-125. PubMed ID: 30668332
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Randomised clinical trial: sodium alginate oral suspension is non-inferior to omeprazole in the treatment of patients with non-erosive gastroesophageal disease.
    Chiu CT; Hsu CM; Wang CC; Chang JJ; Sung CM; Lin CJ; Chen LW; Su MY; Chen TH
    Aliment Pharmacol Ther; 2013 Nov; 38(9):1054-64. PubMed ID: 24024757
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Is the Addition of Sublingual Melatonin to Omeprazole Superior to Omeprazole Alone in the Management of Gastroesophageal Reflux Disease Symptoms: A Clinical Trial.
    Malekpour H; Noori A; Abdi S; Abbasinazari M; Mahboubi A; Ghamsari MA
    Turk J Gastroenterol; 2023 Dec; 34(12):1206-1211. PubMed ID: 37768310
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lansoprazole in the treatment of functional dyspepsia: two double-blind, randomized, placebo-controlled trials.
    Peura DA; Kovacs TO; Metz DC; Siepman N; Pilmer BL; Talley NJ
    Am J Med; 2004 Jun; 116(11):740-8. PubMed ID: 15144910
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Classification of dyspepsia and response to treatment with proton-pump inhibitors.
    Meineche-Schmidt V
    Aliment Pharmacol Ther; 2004 Nov; 20(10):1171-9. PubMed ID: 15569120
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Helicobacter pylori eradication in functional dyspepsia: HEROES trial.
    Mazzoleni LE; Sander GB; Francesconi CF; Mazzoleni F; Uchoa DM; De Bona LR; Milbradt TC; Von Reisswitz PS; Berwanger O; Bressel M; Edelweiss MI; Marini SS; Molina CG; Folador L; Lunkes RP; Heck R; Birkhan OA; Spindler BM; Katz N; Colombo Bda S; Guerrieri PP; Renck LB; Grando E; Hocevar de Moura B; Dahmer FD; Rauber J; Prolla JC
    Arch Intern Med; 2011 Nov; 171(21):1929-36. PubMed ID: 22123802
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.